Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Enliven Therapeutics Inc.
Sponsor

Enliven Therapeutics Inc.

United States 6200 Lookout Road, 80301-3319, United States

About the sponsor

Enliven Therapeutics Inc. is active in hematologic malignancy research, with a focus on chronic myeloid leukemia and targeted treatment development.

  • Chronic myeloid leukemia
  • Targeted oncology
  • Leukemia therapeutics

Its clinical portfolio includes work in disease settings driven by oncogenic signaling abnormalities and treatment-resistant cancer biology.

About Specializations

Enliven Therapeutics Inc. runs clinical trials in conditions such as Neoplasm, HER2 positive breast cancer, Colorectal adenocarcinoma, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

1 clinical trial

Neoplasm+2

Not recruiting
Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Enliven Therapeutics Inc.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.